Drug – bio-affecting and body treating compositions – Containing designated ingredient to stabilize an active...
Patent
1995-04-28
1999-11-23
Harrison, Robert H.
Drug, bio-affecting and body treating compositions
Containing designated ingredient to stabilize an active...
514329, 514946, 514947, 564194, 604 20, A61K 908
Patent
active
059901799
ABSTRACT:
A composition suitable for transdermal electrotransport delivery of an agent through a body surface comprises a free acid/base form of an agent to be delivered by transdermal electrotransport, and a salt form of the agent, and optionally a permeation enhancer. Methods of enhancing transdermal electrotransport delivery and of forming a composition for the enhancement of transdermal electrotransport drug delivery, and a transdermal electrotransport delivery device (10) utilizing the compositions of the invention are disclosed.
REFERENCES:
patent: 4555524 (1985-11-01), Grubert et al.
patent: 4558690 (1985-12-01), Joyce
patent: 4593053 (1986-06-01), Jevne et al.
patent: 4605670 (1986-08-01), Saito et al.
patent: 4637930 (1987-01-01), Konno et al.
patent: 4685911 (1987-08-01), Konno et al.
patent: 4722726 (1988-02-01), Sanderson et al.
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4731241 (1988-03-01), Yamada et al.
patent: 4752285 (1988-06-01), Petelenz et al.
patent: 4820263 (1989-04-01), Spevak et al.
patent: 4879119 (1989-11-01), Konno et al.
patent: 4879274 (1989-11-01), Kamiya et al.
patent: 4882163 (1989-11-01), Guse et al.
patent: 4888354 (1989-12-01), Chang et al.
patent: 4892737 (1990-01-01), Bodor et al.
patent: 4927408 (1990-05-01), Haak et al.
patent: 4940456 (1990-07-01), Sibalis et al.
patent: 4950229 (1990-08-01), Sage, Jr.
patent: 4952560 (1990-08-01), Kigasawa et al.
patent: 4959365 (1990-09-01), Francoeur et al.
patent: 4973303 (1990-11-01), Johnson et al.
patent: 5001139 (1991-03-01), Lawter et al.
patent: 5023085 (1991-06-01), Francoeur et al.
patent: 5026556 (1991-06-01), Drust et al.
patent: 5045319 (1991-09-01), Chien et al.
patent: 5045553 (1991-09-01), Ueda et al.
patent: 5053227 (1991-10-01), Chiang et al.
patent: 5059426 (1991-10-01), Chiang et al.
patent: 5069908 (1991-12-01), Henley
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5128376 (1992-07-01), Saito et al.
patent: 5158537 (1992-10-01), Haak et al.
patent: 5203768 (1993-04-01), Haak et al.
patent: 5288289 (1994-02-01), Haak et al.
patent: 5302172 (1994-04-01), Sage, Jr. et al.
patent: 5320597 (1994-06-01), Sage, Jr. et al.
patent: 5320598 (1994-06-01), Haak et al.
patent: 5328455 (1994-07-01), Lloyd et al.
patent: 5380271 (1995-01-01), Gyory
patent: 5395310 (1995-03-01), Untereker et al.
patent: 5423739 (1995-06-01), Phipps et al.
patent: 5450845 (1995-09-01), Axelgaard
patent: 5464387 (1995-11-01), Haak et al.
patent: 5539972 (1996-07-01), Gyory et al.
patent: 5540669 (1996-07-01), Sage, Jr. et al.
patent: 5795321 (1998-08-01), McArthur et al.
patent: 5840056 (1998-11-01), Atanasoska
Srinivasan et al., J. Pharm. Sci. 79(7):588-91 (1990).
Campbell Patricia S.
Gyory J. Richard
ALZA Corporation
Harrison Robert H.
Miller D. Byron
Stone Steven F.
LandOfFree
Composition and method of enhancing electrotransport agent deliv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method of enhancing electrotransport agent deliv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method of enhancing electrotransport agent deliv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222646